SlideShare una empresa de Scribd logo
1 de 28
High Throughput Screening
Dr Ranjita Santra (Dhali)
Assistant Professor
Department of Clinical & Experimental Pharmacology
STM, Kolkata
What is High Throughput Screening (HTS) ?
• The last two decades have seen astonishing
innovations in technology that have helped the
manual low speed screening to evolve into an
automated, microprocessor controlled robotic
process called High Throughput Screening (HTS)
• HTS - A synergy of chemistry, biology,
engineering and informatics
• Screening of over 50,000-1,00,000
compounds/week
• Screening against the validated biological target
Source: Velpandian T, Sharma HP. In: SK Gupta, editor. Drug Sreening Mrthods. 3rd
edn. New Delhi :The Health Sciences;2016
Goals
1. Identify a molecular structure that:
• Selectively binds to and modulates the
activity of a biological target (e.g., a
protein) of interest [target-based]
• Selectively induces a desired
phenotype in a cell population or
organism of interest [phenotype-based]
Goals
2. Identify hits serve as starting points
for:
• Drug discovery programs
• Medicinal chemistry
• Pharmacology
• Chemical biology programs
• Target identification
• Target validation and mechanism of action
Applications of HTS
• Drug discovery
• Toxicology (in silico toxicology methods)
• Screening of different types of libraries
• Combinatorial Chemistry
• Genomics
• Protein libraries (Antibodies, secreted
soluble protiens)
• Peptide libraries
HTS in Drug Discovery
• Accelerates drug discovery by screening large
compound libraries at a rate that may exceed a
few thousand compounds per day or per week
• Parallel and combinatorial chemical synthesis
generates a vast number of novel compounds
• Characterization of metabolic, pharmacokinetic
and toxicological data about new drugs
General Steps
• Target identification and purification
• Target validation
• Assay development (screening of potential
compounds against target identified)
• High-throughput library (HTL) screening
General Steps
• Lead optimization
• Confirmation of ‘hits’
Hit = A molecule with confirmed activity from primary
HTS assay with a good profile in secondary assays
and with confirmed structure
Lead = Hit series exhibiting the Structure Activity
Relationship(SAR) and demonstrating activities
both in vitro and in vivo
The Array
• Polycarbonate base
film, 0.5-mm thick
• 6x8 array of
coatings
• each sample is 2-5-
μm thick and 10-mm
in diameter
• Flexible silicon
rubber template to
create wells
In Vitro interaction studies
• Chemical microarray
• Chemical -protein interactions
• Enzyme activity inhibition
• Target identification
• Signal pathway elucidation
• Chip based microarray
• Microfluidics helps in mixing of samples
with the targets bound in the chip
• Final signals read by analyzers
(Fluoroscent/simple UV/visible signals)
Other microarrays
• Cytokine based kits
• Angiogenesis responsive biomolecular kits
• Transcription factor analysis kits
Common principle: Biological samples bind to
the Abs bound to the array membrane,
incubation, binding to the secondary Abs and
final tagging of secondary Abs with the signal
emitting molecules (e.g. dyes)
Fluorescence tecniques in HTS
• Fluorescence (FU) based detection of the compounds,
analytes or genetic materials
• Luminescence-based binding assays - core of
interaction of ligand with the biological compartment
• Detection systems - Multimode readers(screening a
single reaction well for different modes e.g. UV, visible
to FU etc.)
• FU microscopes - Identification:
• Entry of fluorescent tagged compound at desired site
• Drug effect on a biomolecule / cellular component
Fluorescent techniques in drug
discovery
• Fluorescence Anisotropy(FA)/
Fluorescence Polarization(FP)
• Time Resolved FA (TRFA)
• Fluorescence Correlation
Spectroscopy(FCS)
• Fluorescence Resonance Energy
Transfer(FRET)
• TR-FRET
• Fluorescence microscopy
Areas of Application
• Receptor-ligand binding assay
• Screening of chemical compounds
• Drug -receptor, drug-enzyme interaction
• Tissue structural analysis
• Gene expression analysis
• Cellular component analysis
Thermal Shift Analysis for HTS
• Identifies ligand interaction with the
proteins
• Fluorescent dye (e.g. sypro orange)
associates and dissociates from the
protein with change in the temperature of
the reaction
• Principle: Binding of ligand to protein,
stabilizing or destabilizing its structure,
final change in the Tm of the protein
Thermal Shift Analysis for HTS
Assessment of:
1.Role of inhibitor in the binding affinity of
ligand with protein
2.Stability of the protein at various pH and salt
conditions
3.Ligand screening for lead identification
Examples: Identification of CA enzyme inhibitors in
glaucoma/AD/PD/Epilepsy)
ER antagonists(Toremefine,tamoxifen) in Cryptococcal
infections
MAP2K4 inhibitor in CA Prostate
Cell based assay
In Vivo Techniques
• Vascular mapping
• Tissue perfusion studies
• Imaging vasculature of brain
• Angiograms of eye
• GIT imaging using endoscopic optics
• Imaging tumours, atherosclerosis,
apoptosis, osteoblastosis
Virtual screening/In Silico drug
development
• Indirect approach using advanced
computer technology to screen newer
compounds based on virtual
coordinates of receptors and signals by
CAMD
• 3D molecular structure of the receptor
and the ligands for docking
• For lead optimization
Unconventional rapid pharmacological
and toxicity testing models
• Zebrafish (angiogenic and anti-
angiogenic effects, heart regeneration)
and Gold fish
• Chick (Anti-cataract activity on lens)
• Nematode C. elegans (growth
retardation with caffeine)
Others
• HTS PK Studies
• HTS-Absorption studies
• HTS-Metabolism studies
• HTS-CYP Inhibition and Induction studies
• HTS Toxicity studies
HTS in the analysis of toxins
• Identification of Marine toxins :
Palytoxins, ciguatoxins, cyclic amines
and tetrodotoxins
• Concern for sea food and sea water
• Steps by EC and EFSA in this regard
Data Acquisition Programs
• Programs constructed using LabView
• Kaleidagraph
• Synergy Software
• Programs constructed using MatLab
• The Mathworks Inc.
Combinatorial Chemistry
• Miniaturization and automation yield high-
throughput experimentation
• Decreased sample size
• Processes almost completely automated
• Quantitative analysis of data
• All steps linked to central database
• Self-updating processes
• Easy to use
• Reliable and versatile
• Combinatorial factory: Larger scale testing to
meet industry specifications
Schematic of The Combinatorial
Factory
Advantages of Combi Chem and
High-Throughput Methods
• Automated, reliable processes
• Quantitative analysis
• Comprehensive database
Advantages of Combi Chem and
High-Throughput Methods
• Automated, reliable processes
• Quantitative analysis
• Comprehensive database
• Test more samples in shorter period of
time
• Minimize cost per sample
• Faster
Thank you!
Questions or
comments?

Más contenido relacionado

La actualidad más candente

SlideShare on Traditional drug design methods
 SlideShare on Traditional drug design methods  SlideShare on Traditional drug design methods
SlideShare on Traditional drug design methods Naveen K L
 
Target identification and validation
Target identification and validationTarget identification and validation
Target identification and validationAshishVerma571
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptxashharnomani
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)suhaspatil114
 
Drug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavDrug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavKashikant Yadav
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Theabhi.in
 
Stages of drug discovery
Stages of drug discoveryStages of drug discovery
Stages of drug discoveryPawanDhamala1
 
Role of Target Identification and Target Validation in Drug Discovery Process
Role of Target Identification and Target Validation in Drug Discovery ProcessRole of Target Identification and Target Validation in Drug Discovery Process
Role of Target Identification and Target Validation in Drug Discovery ProcessPallavi Duggal
 
Target identification in drug discovery
Target identification in drug discoveryTarget identification in drug discovery
Target identification in drug discoverySwati Kumari
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)Satigayatri
 
Pharmacophore mapping
Pharmacophore mapping Pharmacophore mapping
Pharmacophore mapping GamitKinjal
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)Pinky Vincent
 
Traditional and Rational Drug Designing
Traditional and Rational Drug DesigningTraditional and Rational Drug Designing
Traditional and Rational Drug DesigningManish Kumar
 
Target identification
Target identificationTarget identification
Target identificationSachin Jangra
 
1. An Overview of Drug Discovery Process.pdf
1. An Overview of Drug Discovery Process.pdf1. An Overview of Drug Discovery Process.pdf
1. An Overview of Drug Discovery Process.pdfYogeshwary Bhongade
 
economics of drug discovery.pptx
economics of drug discovery.pptxeconomics of drug discovery.pptx
economics of drug discovery.pptxTamannaKumari8
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Shivam Diwaker
 

La actualidad más candente (20)

SlideShare on Traditional drug design methods
 SlideShare on Traditional drug design methods  SlideShare on Traditional drug design methods
SlideShare on Traditional drug design methods
 
Target identification and validation
Target identification and validationTarget identification and validation
Target identification and validation
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptx
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
 
Drug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavDrug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant Yadav
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)
 
Stages of drug discovery
Stages of drug discoveryStages of drug discovery
Stages of drug discovery
 
Traditional drug design
Traditional drug designTraditional drug design
Traditional drug design
 
Role of Target Identification and Target Validation in Drug Discovery Process
Role of Target Identification and Target Validation in Drug Discovery ProcessRole of Target Identification and Target Validation in Drug Discovery Process
Role of Target Identification and Target Validation in Drug Discovery Process
 
Target identification in drug discovery
Target identification in drug discoveryTarget identification in drug discovery
Target identification in drug discovery
 
Docking
DockingDocking
Docking
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
 
Pharmacophore mapping
Pharmacophore mapping Pharmacophore mapping
Pharmacophore mapping
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)
 
Traditional and Rational Drug Designing
Traditional and Rational Drug DesigningTraditional and Rational Drug Designing
Traditional and Rational Drug Designing
 
Target identification
Target identificationTarget identification
Target identification
 
Target Validation
Target ValidationTarget Validation
Target Validation
 
1. An Overview of Drug Discovery Process.pdf
1. An Overview of Drug Discovery Process.pdf1. An Overview of Drug Discovery Process.pdf
1. An Overview of Drug Discovery Process.pdf
 
economics of drug discovery.pptx
economics of drug discovery.pptxeconomics of drug discovery.pptx
economics of drug discovery.pptx
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
 

Destacado

PCL471Laboratory Slides
PCL471Laboratory SlidesPCL471Laboratory Slides
PCL471Laboratory SlidesMaurice Shen
 
High throughput screening
High throughput screeningHigh throughput screening
High throughput screeningajivengan
 
Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Pete Shuster
 
Orexin receptors and their potential as drug targets
Orexin receptors and their potential as drug targetsOrexin receptors and their potential as drug targets
Orexin receptors and their potential as drug targetsDr Ranjita Santra(Dhali)
 
Cell Based Assays (2010) Ella
Cell Based Assays (2010) EllaCell Based Assays (2010) Ella
Cell Based Assays (2010) EllaElakeche
 
Principles of fluorimetry by ANN
Principles of fluorimetry by ANNPrinciples of fluorimetry by ANN
Principles of fluorimetry by ANNAnjali Rarichan
 
Back Rapid lead compounds discovery through high-throughput screening
 Back Rapid lead compounds discovery through high-throughput screening Back Rapid lead compounds discovery through high-throughput screening
Back Rapid lead compounds discovery through high-throughput screeningrita martin
 
High throughput screening (HTS) at iNovacia
High throughput screening (HTS) at iNovaciaHigh throughput screening (HTS) at iNovacia
High throughput screening (HTS) at iNovaciaiNovacia AB
 
Application of fluorescence quenching
Application of fluorescence quenchingApplication of fluorescence quenching
Application of fluorescence quenchingShreya Ray
 
Quenching of Fluorescence
Quenching of FluorescenceQuenching of Fluorescence
Quenching of FluorescenceFatema Zohora
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copyIqrar Ansari
 
Spectrofluorimetry or fluorimetry (www.Redicals.com)
Spectrofluorimetry or fluorimetry (www.Redicals.com)Spectrofluorimetry or fluorimetry (www.Redicals.com)
Spectrofluorimetry or fluorimetry (www.Redicals.com)Goa App
 
Labeled assays
Labeled assays Labeled assays
Labeled assays dream10f
 
FACTORS INFLUENCING FLUORESCENCE INTENSITY
FACTORS INFLUENCING FLUORESCENCE INTENSITYFACTORS INFLUENCING FLUORESCENCE INTENSITY
FACTORS INFLUENCING FLUORESCENCE INTENSITYaishuanju
 

Destacado (20)

PCL471Laboratory Slides
PCL471Laboratory SlidesPCL471Laboratory Slides
PCL471Laboratory Slides
 
High throughput screening
High throughput screeningHigh throughput screening
High throughput screening
 
Bioassay techniques
Bioassay techniquesBioassay techniques
Bioassay techniques
 
Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012
 
Orexin receptors and their potential as drug targets
Orexin receptors and their potential as drug targetsOrexin receptors and their potential as drug targets
Orexin receptors and their potential as drug targets
 
Cell Based Assays (2010) Ella
Cell Based Assays (2010) EllaCell Based Assays (2010) Ella
Cell Based Assays (2010) Ella
 
Toxicokinetics
ToxicokineticsToxicokinetics
Toxicokinetics
 
Fluorometry & its application in lab.assay
Fluorometry & its application in lab.assayFluorometry & its application in lab.assay
Fluorometry & its application in lab.assay
 
My PPT_Drug treatment of Insomnia
My PPT_Drug treatment of InsomniaMy PPT_Drug treatment of Insomnia
My PPT_Drug treatment of Insomnia
 
Principles of fluorimetry by ANN
Principles of fluorimetry by ANNPrinciples of fluorimetry by ANN
Principles of fluorimetry by ANN
 
Back Rapid lead compounds discovery through high-throughput screening
 Back Rapid lead compounds discovery through high-throughput screening Back Rapid lead compounds discovery through high-throughput screening
Back Rapid lead compounds discovery through high-throughput screening
 
High throughput screening (HTS) at iNovacia
High throughput screening (HTS) at iNovaciaHigh throughput screening (HTS) at iNovacia
High throughput screening (HTS) at iNovacia
 
Application of fluorescence quenching
Application of fluorescence quenchingApplication of fluorescence quenching
Application of fluorescence quenching
 
Quenching of Fluorescence
Quenching of FluorescenceQuenching of Fluorescence
Quenching of Fluorescence
 
Drug overdose poisoning
Drug overdose poisoningDrug overdose poisoning
Drug overdose poisoning
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copy
 
Spectrofluorimetry or fluorimetry (www.Redicals.com)
Spectrofluorimetry or fluorimetry (www.Redicals.com)Spectrofluorimetry or fluorimetry (www.Redicals.com)
Spectrofluorimetry or fluorimetry (www.Redicals.com)
 
Drug therapy for heart failure
Drug therapy for heart failureDrug therapy for heart failure
Drug therapy for heart failure
 
Labeled assays
Labeled assays Labeled assays
Labeled assays
 
FACTORS INFLUENCING FLUORESCENCE INTENSITY
FACTORS INFLUENCING FLUORESCENCE INTENSITYFACTORS INFLUENCING FLUORESCENCE INTENSITY
FACTORS INFLUENCING FLUORESCENCE INTENSITY
 

Similar a HTS: High Throughput Screening in Drug Discovery

High Throughput Screening Technology
High Throughput Screening TechnologyHigh Throughput Screening Technology
High Throughput Screening TechnologyUniversity Of Swabi
 
02.High through output screening.pptx
02.High through output screening.pptx02.High through output screening.pptx
02.High through output screening.pptxPurushothamKN1
 
PHYTOCHEMISTRY.ppt studie exames and prepr
PHYTOCHEMISTRY.ppt studie exames and preprPHYTOCHEMISTRY.ppt studie exames and prepr
PHYTOCHEMISTRY.ppt studie exames and preprRabiKhan51
 
High Throughput Screening drugg discovery.pdf
High Throughput Screening drugg discovery.pdfHigh Throughput Screening drugg discovery.pdf
High Throughput Screening drugg discovery.pdfsayedjannatfatema72
 
High-throughput screening (HTS)
High-throughput screening (HTS)High-throughput screening (HTS)
High-throughput screening (HTS)SudipDandapat1
 
Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Jannat985397
 
High throughput screenig
High throughput screenigHigh throughput screenig
High throughput screenigShakeel Sha
 
Drug development approaches
Drug development approaches Drug development approaches
Drug development approaches VIOLINA KALITA
 
2015 bioinformatics bio_cheminformatics_wim_vancriekinge
2015 bioinformatics bio_cheminformatics_wim_vancriekinge2015 bioinformatics bio_cheminformatics_wim_vancriekinge
2015 bioinformatics bio_cheminformatics_wim_vancriekingeProf. Wim Van Criekinge
 
PreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfPreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfsayedjannatfatema72
 
HIGH THROUGHPUT SCREENING.pptx
HIGH THROUGHPUT SCREENING.pptxHIGH THROUGHPUT SCREENING.pptx
HIGH THROUGHPUT SCREENING.pptxSunaynaChoudhary
 
COMPUTER BASED DRUG DESIGN (1).pdf
COMPUTER BASED DRUG DESIGN (1).pdfCOMPUTER BASED DRUG DESIGN (1).pdf
COMPUTER BASED DRUG DESIGN (1).pdfMariam77865
 
2016 bioinformatics i_bio_cheminformatics_wimvancriekinge
2016 bioinformatics i_bio_cheminformatics_wimvancriekinge2016 bioinformatics i_bio_cheminformatics_wimvancriekinge
2016 bioinformatics i_bio_cheminformatics_wimvancriekingeProf. Wim Van Criekinge
 
Drug discovery clinical evaluation of new drugs
Drug discovery clinical evaluation of new drugsDrug discovery clinical evaluation of new drugs
Drug discovery clinical evaluation of new drugsKedar Bandekar
 
Drug discovery clinical evaluation of new drugs
Drug discovery clinical evaluation of new drugsDrug discovery clinical evaluation of new drugs
Drug discovery clinical evaluation of new drugsKedar Bandekar
 
Natural products in drug discovery
Natural products in drug discoveryNatural products in drug discovery
Natural products in drug discoverySAKTHIVEL G
 
New high thoughput screening copy
New high thoughput screening   copyNew high thoughput screening   copy
New high thoughput screening copyMOHANLAL CHOUDHARY
 
Hit to lead drug discovery .pptx
Hit to lead drug discovery .pptxHit to lead drug discovery .pptx
Hit to lead drug discovery .pptxBhupinder Solanki
 
High Throughput Screening for Glycogen and Polyglucosan
High Throughput Screening for Glycogen and PolyglucosanHigh Throughput Screening for Glycogen and Polyglucosan
High Throughput Screening for Glycogen and PolyglucosanBen Decker
 

Similar a HTS: High Throughput Screening in Drug Discovery (20)

High Throughput Screening Technology
High Throughput Screening TechnologyHigh Throughput Screening Technology
High Throughput Screening Technology
 
02.High through output screening.pptx
02.High through output screening.pptx02.High through output screening.pptx
02.High through output screening.pptx
 
PHYTOCHEMISTRY.ppt studie exames and prepr
PHYTOCHEMISTRY.ppt studie exames and preprPHYTOCHEMISTRY.ppt studie exames and prepr
PHYTOCHEMISTRY.ppt studie exames and prepr
 
High Throughput Screening drugg discovery.pdf
High Throughput Screening drugg discovery.pdfHigh Throughput Screening drugg discovery.pdf
High Throughput Screening drugg discovery.pdf
 
High-throughput screening (HTS)
High-throughput screening (HTS)High-throughput screening (HTS)
High-throughput screening (HTS)
 
Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)
 
High throughput screenig
High throughput screenigHigh throughput screenig
High throughput screenig
 
Drug development approaches
Drug development approaches Drug development approaches
Drug development approaches
 
2015 bioinformatics bio_cheminformatics_wim_vancriekinge
2015 bioinformatics bio_cheminformatics_wim_vancriekinge2015 bioinformatics bio_cheminformatics_wim_vancriekinge
2015 bioinformatics bio_cheminformatics_wim_vancriekinge
 
PreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfPreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdf
 
HIGH THROUGHPUT SCREENING.pptx
HIGH THROUGHPUT SCREENING.pptxHIGH THROUGHPUT SCREENING.pptx
HIGH THROUGHPUT SCREENING.pptx
 
COMPUTER BASED DRUG DESIGN (1).pdf
COMPUTER BASED DRUG DESIGN (1).pdfCOMPUTER BASED DRUG DESIGN (1).pdf
COMPUTER BASED DRUG DESIGN (1).pdf
 
2016 bioinformatics i_bio_cheminformatics_wimvancriekinge
2016 bioinformatics i_bio_cheminformatics_wimvancriekinge2016 bioinformatics i_bio_cheminformatics_wimvancriekinge
2016 bioinformatics i_bio_cheminformatics_wimvancriekinge
 
Drug discovery clinical evaluation of new drugs
Drug discovery clinical evaluation of new drugsDrug discovery clinical evaluation of new drugs
Drug discovery clinical evaluation of new drugs
 
Drug discovery clinical evaluation of new drugs
Drug discovery clinical evaluation of new drugsDrug discovery clinical evaluation of new drugs
Drug discovery clinical evaluation of new drugs
 
Sparsh bioinfo.ppt
Sparsh bioinfo.pptSparsh bioinfo.ppt
Sparsh bioinfo.ppt
 
Natural products in drug discovery
Natural products in drug discoveryNatural products in drug discovery
Natural products in drug discovery
 
New high thoughput screening copy
New high thoughput screening   copyNew high thoughput screening   copy
New high thoughput screening copy
 
Hit to lead drug discovery .pptx
Hit to lead drug discovery .pptxHit to lead drug discovery .pptx
Hit to lead drug discovery .pptx
 
High Throughput Screening for Glycogen and Polyglucosan
High Throughput Screening for Glycogen and PolyglucosanHigh Throughput Screening for Glycogen and Polyglucosan
High Throughput Screening for Glycogen and Polyglucosan
 

HTS: High Throughput Screening in Drug Discovery

  • 1. High Throughput Screening Dr Ranjita Santra (Dhali) Assistant Professor Department of Clinical & Experimental Pharmacology STM, Kolkata
  • 2. What is High Throughput Screening (HTS) ? • The last two decades have seen astonishing innovations in technology that have helped the manual low speed screening to evolve into an automated, microprocessor controlled robotic process called High Throughput Screening (HTS) • HTS - A synergy of chemistry, biology, engineering and informatics • Screening of over 50,000-1,00,000 compounds/week • Screening against the validated biological target Source: Velpandian T, Sharma HP. In: SK Gupta, editor. Drug Sreening Mrthods. 3rd edn. New Delhi :The Health Sciences;2016
  • 3. Goals 1. Identify a molecular structure that: • Selectively binds to and modulates the activity of a biological target (e.g., a protein) of interest [target-based] • Selectively induces a desired phenotype in a cell population or organism of interest [phenotype-based]
  • 4. Goals 2. Identify hits serve as starting points for: • Drug discovery programs • Medicinal chemistry • Pharmacology • Chemical biology programs • Target identification • Target validation and mechanism of action
  • 5. Applications of HTS • Drug discovery • Toxicology (in silico toxicology methods) • Screening of different types of libraries • Combinatorial Chemistry • Genomics • Protein libraries (Antibodies, secreted soluble protiens) • Peptide libraries
  • 6. HTS in Drug Discovery • Accelerates drug discovery by screening large compound libraries at a rate that may exceed a few thousand compounds per day or per week • Parallel and combinatorial chemical synthesis generates a vast number of novel compounds • Characterization of metabolic, pharmacokinetic and toxicological data about new drugs
  • 7. General Steps • Target identification and purification • Target validation • Assay development (screening of potential compounds against target identified) • High-throughput library (HTL) screening
  • 8. General Steps • Lead optimization • Confirmation of ‘hits’ Hit = A molecule with confirmed activity from primary HTS assay with a good profile in secondary assays and with confirmed structure Lead = Hit series exhibiting the Structure Activity Relationship(SAR) and demonstrating activities both in vitro and in vivo
  • 9. The Array • Polycarbonate base film, 0.5-mm thick • 6x8 array of coatings • each sample is 2-5- μm thick and 10-mm in diameter • Flexible silicon rubber template to create wells
  • 10. In Vitro interaction studies • Chemical microarray • Chemical -protein interactions • Enzyme activity inhibition • Target identification • Signal pathway elucidation • Chip based microarray • Microfluidics helps in mixing of samples with the targets bound in the chip • Final signals read by analyzers (Fluoroscent/simple UV/visible signals)
  • 11. Other microarrays • Cytokine based kits • Angiogenesis responsive biomolecular kits • Transcription factor analysis kits Common principle: Biological samples bind to the Abs bound to the array membrane, incubation, binding to the secondary Abs and final tagging of secondary Abs with the signal emitting molecules (e.g. dyes)
  • 12. Fluorescence tecniques in HTS • Fluorescence (FU) based detection of the compounds, analytes or genetic materials • Luminescence-based binding assays - core of interaction of ligand with the biological compartment • Detection systems - Multimode readers(screening a single reaction well for different modes e.g. UV, visible to FU etc.) • FU microscopes - Identification: • Entry of fluorescent tagged compound at desired site • Drug effect on a biomolecule / cellular component
  • 13. Fluorescent techniques in drug discovery • Fluorescence Anisotropy(FA)/ Fluorescence Polarization(FP) • Time Resolved FA (TRFA) • Fluorescence Correlation Spectroscopy(FCS) • Fluorescence Resonance Energy Transfer(FRET) • TR-FRET • Fluorescence microscopy
  • 14. Areas of Application • Receptor-ligand binding assay • Screening of chemical compounds • Drug -receptor, drug-enzyme interaction • Tissue structural analysis • Gene expression analysis • Cellular component analysis
  • 15. Thermal Shift Analysis for HTS • Identifies ligand interaction with the proteins • Fluorescent dye (e.g. sypro orange) associates and dissociates from the protein with change in the temperature of the reaction • Principle: Binding of ligand to protein, stabilizing or destabilizing its structure, final change in the Tm of the protein
  • 16. Thermal Shift Analysis for HTS Assessment of: 1.Role of inhibitor in the binding affinity of ligand with protein 2.Stability of the protein at various pH and salt conditions 3.Ligand screening for lead identification Examples: Identification of CA enzyme inhibitors in glaucoma/AD/PD/Epilepsy) ER antagonists(Toremefine,tamoxifen) in Cryptococcal infections MAP2K4 inhibitor in CA Prostate
  • 18. In Vivo Techniques • Vascular mapping • Tissue perfusion studies • Imaging vasculature of brain • Angiograms of eye • GIT imaging using endoscopic optics • Imaging tumours, atherosclerosis, apoptosis, osteoblastosis
  • 19. Virtual screening/In Silico drug development • Indirect approach using advanced computer technology to screen newer compounds based on virtual coordinates of receptors and signals by CAMD • 3D molecular structure of the receptor and the ligands for docking • For lead optimization
  • 20. Unconventional rapid pharmacological and toxicity testing models • Zebrafish (angiogenic and anti- angiogenic effects, heart regeneration) and Gold fish • Chick (Anti-cataract activity on lens) • Nematode C. elegans (growth retardation with caffeine)
  • 21. Others • HTS PK Studies • HTS-Absorption studies • HTS-Metabolism studies • HTS-CYP Inhibition and Induction studies • HTS Toxicity studies
  • 22. HTS in the analysis of toxins • Identification of Marine toxins : Palytoxins, ciguatoxins, cyclic amines and tetrodotoxins • Concern for sea food and sea water • Steps by EC and EFSA in this regard
  • 23. Data Acquisition Programs • Programs constructed using LabView • Kaleidagraph • Synergy Software • Programs constructed using MatLab • The Mathworks Inc.
  • 24. Combinatorial Chemistry • Miniaturization and automation yield high- throughput experimentation • Decreased sample size • Processes almost completely automated • Quantitative analysis of data • All steps linked to central database • Self-updating processes • Easy to use • Reliable and versatile • Combinatorial factory: Larger scale testing to meet industry specifications
  • 25. Schematic of The Combinatorial Factory
  • 26. Advantages of Combi Chem and High-Throughput Methods • Automated, reliable processes • Quantitative analysis • Comprehensive database
  • 27. Advantages of Combi Chem and High-Throughput Methods • Automated, reliable processes • Quantitative analysis • Comprehensive database • Test more samples in shorter period of time • Minimize cost per sample • Faster